HeiLongJiang ZBD Pharmaceutical Co., Ltd. (603567) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

HeiLongJiang ZBD Pharmaceutical Co., Ltd.

Why is HeiLongJiang ZBD Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 2.85%

The company has been able to generate a Return on Capital Employed (avg) of 2.85% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -11.66% and Operating profit at -201.42% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 5.21% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -11.66% and Operating profit at -201.42% over the last 5 years

The company has declared negative results for the last 3 consecutive quarters

ROCE(HY) Lowest at -4.42%
INVENTORY TURNOVER RATIO(HY) Lowest at 0.65 times
DEBTORS TURNOVER RATIO(HY) Lowest at 0.36 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -29.53%, its profits have fallen by -105.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is HeiLongJiang ZBD Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

HeiLongJiang ZBD Pharmaceutical Co., Ltd.

-61.22%

-1.19

30.98%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-32.02%

EBIT Growth (5y)

-203.78%

EBIT to Interest (avg)

1.54

Debt to EBITDA (avg)

16.80

Net Debt to Equity (avg)

0.34

Sales to Capital Employed (avg)

0.21

Tax Ratio

10.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.85%

ROE (avg)

5.21%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.02

EV to EBIT

-13.20

EV to EBITDA

-15.28

EV to Capital Employed

1.01

EV to Sales

18.24

PEG Ratio

Dividend Yield

2.27%

ROCE (Latest)

-7.68%

ROE (Latest)

-26.62%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 652.58 MM

-25What is not working for the Company

NET SALES(HY)

At CNY 60.8 MM has Grown at -94.7%

PRE-TAX PROFIT(Q)

At CNY -224.26 MM has Fallen at -340.9%

NET PROFIT(Q)

At CNY -179.92 MM has Fallen at -338.79%

ROCE(HY)

Lowest at -23.2%

DEBT-EQUITY RATIO (HY)

Highest at 50.62 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

INTEREST(Q)

At CNY 30.57 MM has Grown at inf%

RAW MATERIAL COST(Y)

Grown by 100.91% (YoY

CASH AND EQV(HY)

Lowest at CNY 143.09 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.13 times

Here's what is working for HeiLongJiang ZBD Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 652.58 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for HeiLongJiang ZBD Pharmaceutical Co., Ltd.

Net Sales

At CNY 60.8 MM has Grown at -94.7%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -224.26 MM has Fallen at -340.9%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -179.92 MM has Fallen at -338.79%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 30.57 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 50.62 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Cash and Eqv

Lowest at CNY 143.09 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio

Lowest at 0.13 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 100.91% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales